Research
October 16, 2020
Study by UAMS Researchers Finds Low Risk of COVID-19 Infection from Hospital
People who had recently been in the hospital were 24 times less likely to develop a COVID-19 infection than the general population, University of Arkansas for Medical Sciences (UAMS) researchers found in a study that used data from 45 hospitals. The study focused on people who had been in the hospital for conditions not related…
October 13, 2020
NIH Funds $2.5 Million UAMS Study of Healthy-Food Delivery to Combat Diabetes in Rural Arkansas
LITTLE ROCK — A first-of-its-kind study by UAMS will test whether deliveries of healthy food, along with recipes and education materials, can help reduce type 2 diabetes among food-insecure rural Arkansans. The National Institute of Nursing Research at the National Institutes of Health (NIH) is funding the five-year, $2.5 million study by researchers at the…
October 7, 2020
UAMS Researcher Patents Tool to Study How to Improve Kidney Transplants
A researcher at the University of Arkansas for Medical Sciences (UAMS) has patented a research tool she hopes will bring scientists one step closer to making more kidneys available for lifesaving transplants. More than 100,000 people in the United States are on the waiting list each year for kidney transplants, according to the National Kidney…
September 17, 2020
UAMS Researcher Strengthens Evidence for Connection Between COVID-19 and Pancreatitis
Patients with COVID-19 were at risk of developing pancreatitis in a study conducted by a University of Arkansas for Medical Sciences (UAMS) researcher using data from a large New York health system. The findings support the idea that pancreatitis should be included in the list of gastrointestinal symptoms of COVID-19, something that has been discussed…
September 16, 2020
UAMS Researcher Delgado-Calle Awarded $1.7 Million to Study Bone Health in Myeloma Patients
LITTLE ROCK —Jesus Delgado-Calle, Ph.D., an assistant professor at the University of Arkansas for Medical Sciences (UAMS), has been awarded a National Cancer Institute grant of more than $1.7 million to study ways bone therapy might repair damaged bone and prevent or delay relapse in myeloma patients. Multiple myeloma, a cancer of the plasma cells…
September 9, 2020
SUPER Project Introduces Undergrads to Community-Based Research, Health Disparities
Nine undergraduate students attended the SUPER Project Summer Institute in community-based research and health disparities in early August to prepare for health careers where they hope to make a difference in underserved communities. This allows them to conduct research with the guidance of mentors at their home institution and at UAMS as part of SUPER…
September 8, 2020
$1.9 Million Grant Funds DNA Damage Research by UAMS Scientist Justin Leung, Ph.D.
A $1.9 million grant from the National Institute of General Medical Studies (NIGMS) will allow a scientist at the University of Arkansas for Medical Sciences (UAMS) to advance his research of DNA damage response (DDR) in cancer and genetic disorders.
September 4, 2020
COVID-19 Course for Medical Students Published for International Audience
Imagine teaching a class while using a new technology and the details of the lesson keep changing right up until the last second – all while student and teacher alike are experiencing massive disruptions in their personal lives. The professors at UAMS tasked with teaching the online COVID-19 course for the year three and year…
September 3, 2020
UAMS Research Expo Draws a Virtual Crowd
The UAMS Research Expo on Aug. 25 drew 184 registrants for the virtual event with 25 research service providers presenting via Zoom. Sponsored by the UAMS Translational Research Institute (TRI), the event included overviews of up to five minutes from representatives of the research services. Attendees were able to drop into the event to hear…
UAMS Researchers Awarded $11.4 Million Grant to Continue Study of Cancer Therapy Side Effects
LITTLE ROCK — Led by Marjan Boerma, Ph.D., a team of University of Arkansas for Medical Sciences (UAMS) researchers has received a five-year $11.4 million grant to continue research into the side effects of cancer therapies, including radiation and chemotherapies. The Centers for Biomedical Research Excellence (COBRE), a program of the National Institute of General…
Previous page Next page